References
- Wiggins J. BTS statement on malignant mesothelioma in the UK, 2007. Thorax 2007;62: ii1–ii19.17965072
- Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005;92(3):587–593.10.1038/sj.bjc.660230715668716
- Rahman NM, Ali NJ, Brown G, Chapman SJ, Davies RJ, Downer NJ, et al. Local anaesthetic thoracoscopy: British thoracic society pleural disease guideline 2010. Thorax 2010;65:54–60.
- Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 1997;111(1):106–109.10.1378/chest.111.1.106
- Prakash UBS, Reiman HM. Comparison of needle-biopsy with cytologic analysis for the evaluation of pleural effusion – analysis of 414 cases. Mayo Clinic Proceedings 1985;60(3):158–164.10.1016/S0025-6196(12)60212-23974296
- Rodriguez-Panadero F, Janssen JP, Astoul P. Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. European Respiratory Journal 2006;28(2):409–421.10.1183/09031936.06.00013706
- Hooper C, Lee YCG, Maskell N; BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British thoracic society pleural disease guideline 2010. Thorax 2010;65:4–17.
- Loddenkemper R. Thoracoscopy – state of the art. European Respiratory Journal 1998;11(1):213–22110.1183/09031936.98.11010213
- Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma – a prospective-study of 188 consecutive patients: 1. Diagnosis. Cancer 1993;72(2):389–393.831917010.1002/1097-0142(19930715)72:2<;389::AID-CNCR2820720213>3.0.CO;2-V
- Harris RJ, Kavuru MS, Rice TW, Kirby TJ. The diagnostic and therapeutic utility of thoracoscopy – a review. Chest 1995;108(3):828–841.10.1378/chest.108.3.8287656641